Abstract
Thirty rats were randomly divided into normal control group (group A), non-paederia scandens treatment model group (group B) and paederia scandens treatment model group (group C). The expression of mRNA of TGF-β1, Smad3 and Smad7 was detected by real-time quantitative fluorescence method after 8 weeks. The results showed that, according to the ELISA data of interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α), the difference between group C and group A was extremely significant (P<0.01), which is the same as between group B and group A, and that the difference between group C and group B was significant (P<0.05). The difference between group B and group A was extremely significant (P<0.01). After treatment with paederia scandens, the expression of TGF-β1 mRNA was significantly inhibited, the difference between group C and group A was significant (t=2.245, P<0.05), and the difference between group C and group B was extremely significant (t=1.142, P<0.01). After treatment with Paederia scandens, the expression of Smad3 mRNA was significantly inhibited, the difference between group C and group A was significant (t=2.149, P<0.05), and the difference between group C and group B was extremely significant (t=1.206, P<0.01). Afterwards, the expression of Smad7 mRNA was increased, the difference between group C and group A was significant (t=2.201, P<0.05), and the difference was significant between group C and group B (t=1.007, P<0.01). Paederia scandens can inhibit the expression of TGF-β1 mRNA, decrease the expression of Smad3 mRNA, and increase the expression of Smad7 mRNA. It is shown in our study that in the mechanism of liver fibrosis, there exists a linear channel effect of Smad3 mRNA-(TGF-β1 mRNA)-Smad7 mRNA.
Publication Date
9-28-2019
First Page
6
Last Page
8
DOI
10.13652/j.issn.1003-5788.2019.09.002
Recommended Citation
Yong, YUAN and Chuanzhu, LV
(2019)
"Paederia scandens granules of intervention in rat liver fibrosis model experimental study on TGF-β1 / Smad pathway,"
Food and Machinery: Vol. 35:
Iss.
9, Article 2.
DOI: 10.13652/j.issn.1003-5788.2019.09.002
Available at:
https://www.ifoodmm.cn/journal/vol35/iss9/2
References
[1] 吴孟超, 李梦东. 实用肝病学[M]. 北京: 人民卫生出版社, 2011： 485-488.
[2] 袁勇, 林丹. ETV或LAM加ADV治疗HBeAg阳性慢性乙肝的回顾性分析[J]. 中国热带医学, 2017, 17(1): 101-103.
[3] TANIGUCHI H, KATO N, OTSUKA M, et al. Hepatitis C virus core protein upre gulates transforming growth factor-beta1 transcription[J]. J Med Virol, 2004, 72: 52.
[4] SIMO A, MADALENO J, SILVA N. Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening[J]. BMC Gastroenterology, 2015(15): 73.
[5] SHAWKY ABDELHAMID F, MOHAMED G, ABDEL N, et al. Plasma osteopontin level in chronic liver disease and hepatocellular carcinoma[J]. Hepatitis Monthly, 2015,15(9): e30753.
[6] WADA W, KUWANO H, HASEGAWA Y, et al. The dependence of transforming growth factor-beta-induced collagen production on autocrine factor activin A in hepatic stellate cells[J]. Endocrinology, 2004, 145(6): 2 753-2 759.
[7] GORDILLO-BASTIDAS D, OCEGUERA-CONTRERAS E, SALAZAR-MONTES A, et al. Nrf2 and Snail-1 in the prevention of experimental liver fibrosis by caffeine[J]. World Jurnal of Gastroenterology, 2013, 19(47): 9 020-9 033.
[8] 陶翠玲, 金春英, 赵艳波, 等. 肝纤康治疗慢性病毒性肝炎肝纤维化痰瘀互结证的临床研究[J]. 中医药学报, 2003, 31(4): 6.
[9] 上海中医药大学中医文献研究所. 申江医翠续集: 内科名家姜春华学术经验集[M]. 上海: 上海中医药大学出版社, 2003: 147-148.
[10] 廖建良, 单沛贤. 乌厥、鸡屎藤提取物的抑菌活性研究[J]. 惠州学院学报: 自然科学版, 2016, 36(3): 9-13.
[11] 韩德承. 活血止痛鸡屎藤[J]. 中国中医药报: 农村与社区版, 2012, 8(30): 5.
[12] 袁勇. 鸡矢藤颗粒剂干预大鼠肝纤维化模型 OPN 与 TGF-β1 水平表达的试验研究[J]. 食品与机械, 2018, 34(8): 16-18.
[13] 徐礼通, 杨平. 鳖甲煎丸对慢性乙型肝炎早期肝硬化患者血清肿瘤坏死因子-α和白细胞介素-６的影响[J]. 中国中西医结合消化杂志, 2014, 22(1): 13-15.